Probiotics and zinc in acute infectious gastroenteritis in children: are they effective?

Nutrition

Volumn 23, Issue 6, 2007, Pages 498-506

  Salvatore, Silvia ^a   Hauser, Bruno ^b   Devreker, Thierry ^b   Vieira, Mario C ^c   Luini, Carlo ^a   Arrigo, Silvio ^a   Nespoli, Luigi ^a   Vandenplas, Yvan ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Universitair Ziekenbuis Brussel Kinderen   (Belgium)

^c HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

Author keywords

Biotherapeutic agent; Diarrhea; Gastroenteritis; Probiotic; Zinc

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; LACTEOL FORT; ORAL REHYDRATION SOLUTION; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ZINC;

ACUTE GASTROENTERITIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ELECTROLYTE TRANSPORT; HOSPITAL INFECTION; HUMAN; IMMUNOMODULATION; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS CASEI; ORAL REHYDRATION THERAPY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; ROTAVIRUS; SACCHAROMYCES BOULARDII; TRAVELLER DIARRHEA; VIRUS INFECTION;

CHILD; CHILD, PRESCHOOL; DIARRHEA; FLUID THERAPY; GASTROENTERITIS; HUMANS; LACTOBACILLUS; PROBIOTICS; ROTAVIRUS INFECTIONS; SACCHAROMYCES; SEVERITY OF ILLNESS INDEX; TRACE ELEMENTS; TREATMENT OUTCOME; ZINC;

LACTOBACILLUS CASEI; ROTAVIRUS; SACCHAROMYCES BOULARDII;

EID: 34249982298     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.03.008     Document Type: Review

References (94)

1. Temmerman R. Quality analysis and label correctness of commercial probiotic products. Innov Food Technol 2 (2002) 72-73
2. Isolauri E., Juntunen M., Rautanen T., Sillanaukee P., and Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88 (1991) 90-97
3. Raza S., Graham S.M., and Allen S.J. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 14 (1995) 107-111
4. Shornikova A.V., Isolauri E., Burkanova L., Lukovnikova S., and Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 86 (1997) 460-465
5. Shornikova A.V., Casas I.A., Mykkanen H., Salo E., and Vesikari T. Bacteriotherapy with Lactobacillus reuteri in Rotavirus gastroenteritis. Pediatr Infect Dis J 16 (1997) 1103-1107
6. Guarino A., Berni Canani R., Spagnuolo M.I., Bisceglia M., Boccia M.C., and Rubino A. Oral bacterial therapy reduces the duration of symptoms and viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 25 (1997) 516-519
7. Guandalini S., Pensabene L., Zikri M.A., Dias J.A., Casali L.G., Hoekstra H., et al. Lactobacillus GG administered in oral rehydration solution in children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30 (2000) 214-216
8. Simakachorn N., Pichaipat V., Rithipornpaisarn P., Kongkaew C., Tongpradit P., and Varavithya W. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr 30 (2000) 68-72
9. Szymanski H., Pejcz J., Jawien M., Chmielarczyk A., Strus M., and Heczko P.B. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains-a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 23 (2006) 247-253
10. Costa-Ribeiro H., Ribeiro T.C., Mattos A.P., Valois S.S., Neri D.A., Almeida P., et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 36 (2003) 112-115
11. Salazar-Lindo E., Miranda-Langschwager P., Campos-Sanchez M., Chea-Woo E., and Sack R.B. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048] BMC. Pediatrics 4 (2004) 18
12. Khanna V., Alam S., and Malik A. Efficacy of tyndallized Lactobacillus acidophilus in acute diarrhea. Indian J Pediatr 72 (2005) 935-938
13. Sarker S.A., Sultana S., Fuchs G.J., Alam N.H., Azim T., Brussow H., and Hammarstrom L. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116 (2005) e221-e228
14. Van Niel C.W., Feudtner C., Garrison M.M., and Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109 (2002) 678-684
15. Szajewska H., and Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33 (2001) S17-S25
16. Huang J.S., Bousvaros A., Lee J.W., Diaz A., and Davidson E.J. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47 (2002) 2625-2634
17. Allen S.J., Okoko B., Martinez E., Gregorio G., and Dans L.F. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2 (2004) CD003048
18. Höchter W., Chase D., and Hagenhoff G. Saccharomyces boulardii bei akuter Erwachsenendiarrhoe. Munch Med Wschr 132 (1990) 188-192
19. Cetina-Sauri G., and Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Ann Pediatr 41 (1994) 397-400
20. Kurugol Z., and Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94 (2005) 44-47
21. Villarruel G., Rubio D.M., Lopez F., Cintioni J., Gurevech R., Romero G., and Vandenplas Y. Saccharomyces boulardii in acute childhood diarrhea: a randomized, placebo-controlled study. Acta Paediatr 96 (2007) 538-541
22. Billoo A.G., Memon M.A., Khaskheli S.A., Murtaza G., Iqbal K., Saeed Shekhani M., and Siddiqi A.Q. Role of a probiotics (Saccharomyces boulardii) in the management and prevention of diarrhea. World J Gastroenterol 12 (2006) 4557-4560
23. Szajewska H., Skorka A., and Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25 (2007) 257-264
24. Lee Y.K., and Salminen S. The coming age of probiotics. Trends Food Sci Technol 6 (1995) 241-245
25. Saran S., Gopalan S., and Krishna T.P. Use of fermented foods to combat stunting and failure to thrive. Nutrition 18 (2002) 393-396
26. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Nase L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322 (2001) 1-5
27. Thibault H., Aubert-Jacquin C., and Goulet O. Effects of long-term consumption of a fermented formula (with Bifidobacterium breve c50 and Str. thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 39 (2004) 147-152
28. Weizman Z., Asli G., and Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115 (2005) 5-9
29. Chouraqui J.P., Van Egroo L.D., and Fichot M.C. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38 (2004) 288-292
30. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., and Yolken R.H. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of Rotavirus. Lancet 344 (1994) 1046-1049
31. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., and Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138 (2001) 361-365
32. Oberhelman R.A., Gilman R.H., Sheen P., Taylor D.N., Black R.E., Cabrera L., et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 134 (1999) 15-20
33. Mastretta E., Longo P., Laccisaglia A., Balbo L., Russo R., Mazzaccara A., and Gianino P. Effect of Lactobacillus GG and breast-feeding in the prevention of Rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 35 (2002) 527-531
34. Doron S., Snydman D.R., and Gorbach S.L. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 34 (2005) 483-498
35. Oksanen P.J., Salminen S., Saxelin M., Hamalainen P., Ihantola-Vormisto A., Muurasniemi-Isoviita L., et al. Prevention of traveler's diarrhoea by Lactobacillus GG. Ann Med 22 (1990) 53-56
36. Hilton E. Lactobacillus GG in prevention of travellers' diarrhea. J Travel Med 4 (1997) 41-43
37. Markowitz J.E., and Bengmark S. Probiotics in health and disease in the pediatric patient. Food Nutr 49 (2002) 127-141
38. Kollaritsch H. Traveller's diarrhea among Austrian tourists to warm climate countries: II. Clinical features. Eur J Epidemiol 5 (1989) 355-362
39. McFarland L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 5 (2007) 97-105
40. Szajewska H., and Mrukowicz J.Z. Use of probiotics in children with acute diarrhea. Pediatr Drugs 7 (2005) 111-122
41. Kaila M., Isolauri E., Soppi E., Virtanen E., Laine S., and Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 32 (1992) 141-144
42. Kaila M., Isolauri E., Saxelin M., Arvilommi H., and Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute Rotavirus diarrhoea. Arch Dis Child 72 (1995) 51-53
43. Fukushima Y. Effect of a probiotic formula on intestinal IgA production in healthy children. Int J Food Microbiol 42 (1998) 39-44
44. De Simone C., Ciardi A., Grassi A., Lambert Gardini S., Tzantzoglou S., Trinchieri V., et al. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 14 (1992) 331-340
45. Halpern G.M., Vruwink K.G., and Van de Water J. Influence of long-term yoghurt consumption in young adults. Int J Immunother 7 (1991) 205-210
46. Schultz M., Linde H.J., Lehn N., Zimmermann K., Grossmann J., Falk W., and Scholmerich J. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 70 (2003) 165-173
47. Pessi T., Sutas Y., Hurme M., and Isolauri E. Interleukin 10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30 (2000) 1804-1808
48. Rautava S., Kalliomaki M., and Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109 (2002) 119-121
49. Marin M.L., Tejada-Simon M.V., Lee J.H., Murtha J., Ustunol Z., and Pestka J.J. Stimulation of cytokine production in clonal macrophage a cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J Food Prot 61 (1998) 859-864
50. Miettinen M., Matikainen S., Vuopio-Varkila J., Pirhonen J., Varkila K., Kurimoto M., and Julkunen I. Lactobacilli and Streptococci induce interleukin-12, IL18, and INF g production in human peripheral mononuclear cells. Infect Immun 66 (1998) 6058-6062
51. Resta-Lenert S., and Barrett K.E. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130 (2006) 731-746
52. Bernet M.F., Brassart D., Neeser J.R., and Servin A.L. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35 (1994) 483-48
53. Juntunen M., Kirjavainen P.V., Ouwehand A.C., Salminen S.J., and Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during ROTAvirus infection. Clin Diagn Lab Immunol 8 (2001) 293-296
54. Buts J.P., Bernasconi P., Van Craynest M.P., Maldague P., and De Meyer R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 20 (1986) 192-196
55. Dahan S., Dalmasso G., Imbert V., Peyron J.F., Rampal P., and Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71 (2003) 766-773
56. Sougioultzis S., Simeonidis S., Bhaskar K.R., Chen X., Anton P.M., Keates S., et al. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343 (2006) 69-76
57. Buts J.P., and De Keyser N. Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51 (2006) 1485-1492
58. Land M.H., Rouster-Stevens K., Woods C.R., Cannon M.L., Cnota J., and Shetty A.K. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 (2005) 178-181
59. Enache-Angoulvant A. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 41 (2005) 1559-1568
60. Cassone M., Serra P., Mondello F., Girolamo A., Scafetti S., Pistella E., and Venditti M. Outbreak of S. cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Clin Microbiol 41 (2003) 5340-5343
61. Adams M.A. Safety of industrial lactic acid bacteria. J Biotechnol 68 (1999) 171-178
62. Ishibashi N., and Yamazaki S. Probiotics and safety. Am J Clin Nutr 73 (2001) S465-S470
63. WHO/UNICEF, WHO/UNICEF joint statement: clinical management of acute diarrhoea (2004), United Nations Children's Fund/World Health Organization, Geneva, Switzerland 1-8
64. Bhutta Z.A., Bird S.M., Black R.E., Brown K.H., Gardner J.M., Hidayat A., et al., Zinc Investigators' Collaborative Group. Therapeutic effects of oral zinc in acute and persistent diarrhoea in children in developing countries: pooled analysis of randomised controlled trials. Am J Clin Nutr 72 (2000) 1516-1522
65. Berni Canani R., and Ruotolo S. The dawning of the "zinc era" in the treatment of pediatric acute gastroenteritis worldwide?. J Pediatr Gastroenterol Nutr 42 (2006) 253-255
66. Bobat R., Coovadia H., Stephen C., Naidoo K.L., McKerrow N., Black R.E., and Moss W.J. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 366 (2005) 1862-1867
67. Bhatnagar S., Bahl R., Sharma P.K., Kumar G.T., Saxena S.K., and Bhan M.K. Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial. J Pediatr Gastroenterol Nutr 38 (2004) 34-40
68. INCLEN Childnet Zinc Effectiveness for Diarrhoea Group. Zinc supplementation in children with acute diarrhea is acceptable, does not interfere with oral rehydration and reduces the use of other medications: a randomized trial in five countries. J Pediatr Gastroenterol Nutr 42 (2006) 300-305
69. Brooks W.A., Santosham M., Roy S.K., Faruque A.S., Wahed M.A., Nahar K., et al. Efficacy of zinc in young infants with acute watery diarrhoea. Am J Clin Nutr 82 (2005) 605-610
70. Bhan M.K., and Bhandari N. The role of zinc and vitamin a in persistent diarrhea among infants and young children. J Pediatr Gasrtenterol Nutr 26 (1998) 446-453
71. Baqui A.H., Black R.E., El Arifeen S., Yunus M., Zaman K., Begum N., et al. Zinc therapy for diarrhoea increased the use of oral rehydration therapy and reduced the use of antibiotics in Bangladeshi children. J Health Popul Nutr 22 (2004) 440-442
72. Bhandari N., Mazumder S., Taneja S., Dube B., Black R.E., Fontaine O., et al. A pilot test of the addiction of zinc to the current case management package of diarrhoea in a primary healthcare setting. J Pediatr Gastroenterol Nutr 41 (2005) 625-627
73. Shamir R., Makhoul I.R., Etzioni A., and Shehadeh N. Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age. J Am Coll Nutr 24 (2005) 370-375
74. Cruz J.A. Dietary habits and nutritional status in adolescents over Europe-Southern Europe. Eur J Clin Nutr 54 suppl 1 (2000) S29-S35
75. Briefel R.R., Bialostosky K., Kennedy-Stephenson J., McDowell M.A., Ervin R.B., and Wright J.D. Zinc intake of the U.S. population: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Nutr 130 (2000) S1367-S1373
76. Castillo-Duran C., Vial P., and Uauy R. Trace mineral balance during acute diarrhea in infants. J Pediatr 113 (1988) 452-457
77. Ruz M., and Solomons N.W. Fecal excretion of endogenous zinc during oral rehydration therapy for acute diarrhea. J Trace Elem Exp Med 7 (1995) 89-100
78. Sachdev H.P., Mittal N.K., Mittal S.K., and Yadav H.S. A controlled trial on utility of oral zinc supplementation in acute dehydrating diarrhoea in infants. J Pediatr Gastroenterol Nutr 7 (1988) 877-881
79. Strand T.A., Chandyo R.K., Bahl R., Sharma P.R., Adhikari R.K., Bhandari N., et al. Effectiveness and efficacy of zinc for the treatment of acute diarrhea in young children. Pediatrics 109 (2002) 898-903
80. Roy S.K., Tomkins A.M., Akramuzzaman S.M., Behrens R.H., Haider R., Mahalanabis D., and Fuchs G. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child 77 (1997) 196-200
81. Baqui A.H., Black R.E., El Arifeen S., Yunus M., Chakraborty J., Ahmed S., and Vaughan J.P. Effect of zinc supplementation during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ 325 (2002) 1059-1063
82. Zinc Investigators' Collaborative Group. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr 135 (1999) 689-697
83. Edejer T.T., Aikins M., Black R., Wolfson L., Hutubessy R., and Evans D.B. Cost effectiveness analysis of strategies for child health in developing countries. BMJ 331 (2005) 1177-1182
84. Wapnir R.A. Zinc Deficiency, malnutrition and the gastrointestinal tract. J Nutr 130 (2000) S1388-S1392
85. Moran J.R., and Lewis J.C. The effects of zinc deficiency on intestinal permeability: an ultrastructural study. Pediatr Res 19 (1985) 968-973
86. Shankar A.H., and Prasad A.S. Zinc and immune function: the biologic basis of altered resistance to infection. Am J Clin Nutr 68 suppl 2 (1998) 447-463
87. Sazawal S., Jalla S., Mazumder S., Sinha A., Black R.E., and Bhan M.K. Effect of zinc supplementation on cell mediated immunity and lymphocyte subsets in preschool children. Indian Pediatr 34 (1997) 689-697
88. Fraker P.J., King L.E., Laako T., and Vollmer T.L. The dynamic link between the integrity of the immune system and zinc dtatus. J Nutr 130 (2000) S1399-S1406
89. Berni Canani R., Cirillo P., and Buccigrossi V. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis 191 (2005) 1072-1077
90. Roselli M., Finamore A., Garaguso I., Britti M.S., and Mengheri E. Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli (ETEC). J Nutr 133 (2003) 4077-4082
91. Raqib R., Roy S.K., Rahman M.J., Azim T., Ameer S.S., Chisti J., and Andersson J. Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis. Am J Clin Nutr 79 (2004) 444-450
92. Brown K.H., Peerson J.M., and Allen L.H. Effect of zinc supplementation on children's growth: a meta-analysis of intervention trials. Bibl Nutr Dieta 54 (1997) 76-83
93. Sandstead H.H., Penland J.G., Alcock N.W., Dayal H.H., Chen X.C., Li J.S., et al. Effects of repletion with zinc and other micronutrients on neuropsychologic performance and growth of Chinese children. Am J Clin Nutr 68 suppl (1998) S470-S475
94. Nasrin D., Larson C.P., Sultana S., and Khan T.U. Acceptability of and adherence to dispersible zinc tablet in the treatment of acute childhood diarrhoea. J Health Popul Nutr 23 (2005) 215-221